#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infantile spasms Craniopharyngioma Autoimmune myositis Bulbospinal muscular atrophy congenital Haemophilia B without inhibitors Paraganglion neoplasm Staphylococcal infection Endocrine ophthalmopathy Pulmonary hypertension Sarcoidosis Krabbe's disease Pleural mesothelioma Penile squamous cell carcinoma Rectal cancer Undifferentiated sarcoma More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Diagnostics Mantle cell lymphoma – Trials in Disease Hereditary ataxia – Life with Disease Malignant fibrous histiocytoma – Life with Disease Primary biliary cholangitis – Treatment Ornithine transcarbamoylase deficiency – Basic Information Mantle cell lymphoma refractory – Diagnostics Alport’s syndrome – Treatment Adrenogenital syndrome – Trials in Disease Mucopolysaccharidosis I – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Warfarin Sodium Magrolimab Durvalumab ROPINIROLE RUBIDIUM CHLORIDE Islatravir Vismodegib Apremilast Alnus Glutinosa Pollen Telisotuzumab Vedotin Desoximetasone Vafidemstat Amitriptyline RIMIDUCID Donanemab Macitentan Tamibarotene Gemlapodect Amiloride Cemdisiran More therapies…

    Learn about Your Condition

    Myxoid liposarcoma Hepato-lenticular degeneration Skin ulcer Hidradenitis Von Willebrand's disease Urethral stenosis Breast proliferative changes Insomnia Keratosis follicular Naevoid melanoma Alopecia areata Non-obstructive cardiomyopathy Diabetic foot infection Staphylococcal bacteraemia Hyperphagia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Food allergy

  • Study on the Safety and Tolerability of INP20 for Peanut Allergy in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Food allergy
    Spain

  • Study on the Safety and Effectiveness of Low-Dose Oral Immunotherapy with Omalizumab for Children with Severe Cow’s Milk Allergy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Milk allergy
    • Food allergy
    Investigated Drugs:
    • Omalizumab
    Spain

  • Omalizumab monotherapy for patients with vegetable (plant‑based food) allergy due to LTP and profilin sensitization

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Food allergy
    Investigated Drugs:
    • Omalizumab
    Spain

  • Study of DBV712 skin patch safety in children aged 1-3 years with peanut allergy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Arachis Hypogaea (762)
    • Arachis Hypogaea Extract
    • Arachis Hypogaea Flour
    France Ireland The Netherlands Spain

  • Study on Long-term Benefits and Safety of DBV712 for Children with Peanut Allergy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Food allergy
    Investigated Drugs:
    • Arachis Hypogaea Extract
    • Arachis Hypogaea Flour
    Germany The Netherlands

  • Study on the Effectiveness and Safety of DBV712 for Peanut Allergy in Children Aged 4-7

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Arachis Hypogaea (762)
    • Arachis Hypogaea Extract
    • Defatted Powder Of Arachis Hypogaea L., Semen (Peanuts)
    France Germany Ireland The Netherlands Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!